Table 1 Characteristics of patients with and without UDS
From: Intracerebral hemorrhage: who gets tested for methamphetamine use and why might it matter?
Variables | UDS (n = 355) | No UDS (n = 237) | p |
|---|---|---|---|
Age | 60 ± 16 | 66 ± 15 | < 0.001 |
Male | 222 (62.5) | 119 (50.2) | 0.003 |
Race | |||
White | 150 (42.3) | 99 (41.8) | 0.907 |
Hispanic | 112 (31.5) | 65 (27.4) | 0.283 |
African American | 13 (3.7) | 15 (6.3) | 0.134 |
Asian | 80 (22.5) | 60 (25.3) | 0.435 |
Hypertension | 244 (68.7) | 161 (67.9) | 0.837 |
Diabetes | 85 (23.9) | 76 (32.1) | 0.030 |
Hyperlipidemia | 66 (18.6) | 52 (21.9) | 0.318 |
Coronary Artery Disease | 33 (9.3) | 31 (13.1) | 0.146 |
Anticoagulant use | 25 (7.0) | 33 (13.9) | 0.016 |
Smoking | 69 (19.4) | 28 (11.8) | 0.014 |
History of Meth use | 29 (8.2) | 2 (0.8) | < 0.001 |
Heart rate | 87 ± 19 | 86 ± 21 | 0.501 |
Systolic blood pressure, (mmHg) | 181 ± 41 | 174 ± 37 | 0.033 |
Diastolic blood pressure, (mmHg) | 100 ± 24 | 91 ± 21 | < 0.001 |
NIHSS | 12 (5, 25) | 11 (2, 24) | 0.165 |
NIHSS 0–4 | 81 (22.8) | 87 (36.7) | < 0.001 |
NIHSS 5–9 | 68 (19.2) | 21 (8.9) | 0.001 |
NIHSS > 9 | 206 (58.0) | 129 (54.4) | 0.398 |
GCS | 13 (6, 15) | 13 (6, 15) | 0.899 |
GCS < 9 | 115 (32.4) | 77 (32.5) | 0.981 |
ICH location | 0.654 | ||
Hypertensivea | 212 (59.7) | 136 (57.4) | |
Atypical | 135 (38.0) | 93 (39.2) | |
Multifocal | 8 (2.3) | 8 (3.4) | |
IVH | 173 (48.7) | 122 (51.5) | 0.513 |
ICH score | 1 (0, 3) | 2 (1, 3) | 0.503 |
EVD | 87 (24.5) | 39 (16.5) | 0.019 |
Intubation | 158 (44.5) | 101 (42.6) | 0.650 |